Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.
The conversation is about hair loss treatments, specifically the anticipation for the release of a new treatment, GT20029, by 2028. Users are discussing their experiences with current treatments like finasteride and dutasteride, and the potential of future treatments, including FAK inhibitors and verteporfin trials.
The conversation discusses future hair loss treatments, with mentions of dutasteride potentially gaining FDA approval and increased popularity. Skepticism remains about significant advancements due to limited funding and reliance on cosmetic companies.
A user experienced increased hair shedding after 2.5 years on finasteride and 5 months on minoxidil, possibly due to recent additions like supplements and microneedling. Others shared similar experiences with minoxidil shedding, suggesting it may be a normal part of the process, with hair often growing back thicker.
A user shared positive results from using 0.5 mg finasteride daily for 3.5 months, noting no side effects and visible hair regrowth. Others commented on their experiences, with some expressing hope and others cautioning about potential side effects.